Automation index

How much of a Export salesperson’s job can AI already do?

An Incoterm comes earlier. Closing the order so it actually crosses do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

27%

AI can already do 27% of this job.

#142 / 623

Export salesperson

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Book, trade fair and the lead. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Quote, Incoterm and the one who wants cheap CIF. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Order, credit and the one who does not pay. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Customs, the delay and not promising the date. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The agent, the territory and not stepping on each other. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Close it, and that it crosses. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

23%

#311 / 623

Radiation oncologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Contouring, fractions and the dose plan. Estimate No public source provides a precise figure. This is our estimate.	16%	48%	+7.7
Clinic, the tumour and what can be irradiated. Estimate No public source provides a precise figure. This is our estimate.	18%	18%	+3.2
Simulation, immobilisation and the machine day. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Side effects, pauses and the patient who cannot take it. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
Board, the surgeon and the medical oncologist. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Signing the plan and the dose that does not erase. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		23%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low